High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.0M
$10,023,532
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CEO
Other
|
2025-10-22 | $370,082 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Patel Sanj K
• CEO
10b5-1 SellΔOwn -46.6%
2025-10-22
$3,781,654Large
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CEO
10b5-1 SellΔOwn -46.6%
|
2025-10-22 | $3,781,654Large | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CEO
Other
|
2025-10-21 | $149,458 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Patel Sanj K
• CEO
10b5-1 SellΔOwn -26.0%
2025-10-21
$1,524,863Large
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CEO
10b5-1 SellΔOwn -26.0%
|
2025-10-21 | $1,524,863Large | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CEO
Other
|
2025-10-20 | $460,742 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Patel Sanj K
• CEO
10b5-1 SellΔOwn -16.6%
2025-10-20
$4,717,015Largex2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CEO
10b5-1 SellΔOwn -16.6%
|
2025-10-20 | $4,717,015Largex2 | S | Form 4 |